| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,250 |
5,341 |
$210K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,754 |
1,624 |
$110K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
420 |
387 |
$46K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
704 |
651 |
$32K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
552 |
510 |
$29K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
282 |
249 |
$24K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
332 |
303 |
$17K |
| 59400 |
Routine obstetric care including antepartum care, vaginal delivery, and postpartum care |
26 |
13 |
$15K |
| 87634 |
|
153 |
149 |
$12K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
251 |
226 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
270 |
247 |
$8K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
120 |
115 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
585 |
558 |
$7K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
127 |
121 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
248 |
227 |
$6K |
| 90686 |
|
442 |
410 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
80 |
70 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
64 |
56 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
294 |
274 |
$3K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
40 |
36 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
51 |
39 |
$2K |
| 76818 |
|
32 |
12 |
$2K |
| 76801 |
|
14 |
13 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
23 |
21 |
$530.16 |
| 90670 |
|
53 |
53 |
$506.68 |
| 71020 |
|
13 |
12 |
$448.80 |
| 74018 |
|
14 |
14 |
$408.95 |
| 90707 |
|
36 |
33 |
$390.66 |
| 90716 |
|
35 |
32 |
$377.52 |
| 90734 |
|
16 |
15 |
$317.42 |
| 90696 |
|
19 |
17 |
$223.38 |
| 90633 |
|
14 |
14 |
$157.68 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
13 |
$118.52 |
| 90651 |
|
15 |
13 |
$76.48 |
| 81003 |
|
15 |
13 |
$22.40 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
12 |
12 |
$11.20 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
113 |
105 |
$0.01 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
111 |
88 |
$0.00 |
| 3008F |
|
55 |
51 |
$0.00 |
| 2014F |
|
121 |
108 |
$0.00 |
| 96160 |
|
299 |
277 |
$0.00 |